Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis

J. Das*, J. A. Snowden, J. Burman, M. S. Freedman, H. Atkins, M. Bowman, R. K. Burt, R. Saccardi, C. Innocenti, S. Mistry, P. J. Laud, H. Jessop, B. Sharrack

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis'. Together they form a unique fingerprint.

INIS

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science